CLL Coverage from Every Angle
Editor:
Jennifer R. Brown, MD, PhD
Advertisement
Advertisement

Ongoing CE Activities

Addressing Current Questions and Controversies in the Management of Lymphomas and Chronic Lymphocytic Leukemia
Applying Guideline Updates and Real-World Experience in CLL: Experts Review State-of-the-Art Evidence and Address Clinical Challenges
CLL Expert Guidance on Sequencing Therapy & Novel Agents
Hematologic Malignancies: A Review of Key Clinical Studies CCO Independent Conference Highlights of the 2019 ASCO Annual Meeting CME
CAR-T Cell Therapy for Blood Cancer Patients
Chronic Lymphocytic Leukemia Update, Issue 1, 2019
City of Hope: State of the Art of Cancer Therapeutics: Focus on Chronic Lymphocytic Leukemia
Clinical Advances: Individualizing Treatment for Chronic Lymphocytic Leukemia
Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Multiple Myeloma
Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia
Conversations With Oncology Investigators: Bridging the Gap Between Research and Patient Care
Core Strategies in CLL to Mitigate Risks & Optimize Patient-Centered Care
Emergence of Chemotherapy-Free Regimens for Previously Untreated and Relapsed/Refractory CLL: Highlights from ASCO 2019
Evolving Strategies in First-Line Chronic Lymphocytic Leukemia: Is There a Role for Chemoimmunotherapy?
Highlights from the 3rd Annual Seminar Series on Hematologic Malignancies & Precision Medicine: An Expert Q&A
IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR
Improving Outcomes for Patients With Patients With Chronic Lymphocytic Leukemia
New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia - Module - 2
Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents Novel Therapies and Actual Cases from Practice
Oncology Today with Dr Neil Love: Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia
Practicing in an Era of Chemotherapy-Free Regimens for Relapsed/Refractory Chronic Lymphocytic Leukemia
Proceedings from the First Annual Oncology Nursing Retreat-Chronic Lymphocytic Leukemia
Recorded Presentations From the NCCN 2019 Annual Congress: Hematologic Malignancies™
Copyright © 2022 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.